Here's Why Quants Are Getting Into Cannabis InvestingPosted by On

Cannabis investors have seen several cycles of hype and disappointment over the years. But quantitative investors are eyeing some opportunities in the sector today.

The Motley Fool sat down with Meb Faber, CEO and CIO of Cambria Investment Management, to talk about Cambria Cannabis ETF (NYSEMKT:TOKE). The quant firm’s low-cost cannabis fund seeks exposure to the broader marijuana industry with top holdings including GW Pharmaceuticals (NASDAQ:GWPH), Altria (NYSE:MO), and Canopy Growth (NASDAQ:CGC).

Corinne Cardina: Hello there, Meb. How are you?

Meb Faber: What’s up?

Cardina: Welcome to Fool Live. We’re live.

Faber: Great to be here. Good morning.

Cardina: Good morning. So great to meet you. I was just telling our guests, we are so excited to welcome you, CEO and CIO of Cambria Investment Management. You all have an ETF called Cambria Cannabis ETF (NYSEMKT:TOKE), and the ticker is TOKE, so that’s pretty fun. I’m going to put that in the chat, so that our attendees can get that ticker, if they’re interested. We’re going to spend the next 15 minutes talking about this ETF and zooming out a little bit to the cannabis landscape. Then the…

Original Author Link click here to read complete story..

News

cannabisHere039sinvestingQuants

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.